NewsBenzingaImmunityBio 第三季度调整后每股收益(EPS)为-0.09美元,低于-0.08美元的预期;销售额为4,884.1万美元,低于5,925.0万美元的预期 ImmunityBio 第三季度调整后每股收益(EPS)为-0.09美元,低于-0.08美元的预期;销售额为4,884.1万美元,低于5,925.0万美元的预期 Benzinga 2026.11.09 13:01 (GMT+0) Open on Benzinga Other news Peter Schiff Says AI Stocks Aren’t the ‘Only Bubble’ Out There: The Economist Predicts All Will ‘Deflate,’ but Prediction Market Isn’t Buying It Taiwan Semiconductor (TSM) Stock Trending After Nvidia Posts Strong Q3 Results: What You Should Know Binance Spot and Convert Add 7 bStocks Trading Pairs ‘Not the Nvidia I Know’: Jim Cramer Questions Employee Morale; Colette Kress Has ‘High Confidence’ Staff Still ‘Enjoy’ Their Work Abraxas Capital Moves $109 Million USDC to Binance After Closing Its ~$200 Million Hyperliquid Positions Verisk Analytics, Inc. (VRSK) Presents at J.P. Morgan Ultimate Services Investor Conference 2026 Transcript
Peter Schiff Says AI Stocks Aren’t the ‘Only Bubble’ Out There: The Economist Predicts All Will ‘Deflate,’ but Prediction Market Isn’t Buying It
‘Not the Nvidia I Know’: Jim Cramer Questions Employee Morale; Colette Kress Has ‘High Confidence’ Staff Still ‘Enjoy’ Their Work
Abraxas Capital Moves $109 Million USDC to Binance After Closing Its ~$200 Million Hyperliquid Positions
Verisk Analytics, Inc. (VRSK) Presents at J.P. Morgan Ultimate Services Investor Conference 2026 Transcript